Zuora, Inc. (NYSE:ZUO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $11.86.
Several brokerages have recently issued reports on ZUO. Needham & Company LLC restated a “buy” rating and issued a $15.00 target price on shares of Zuora in a report on Thursday, August 22nd. Canaccord Genuity Group reiterated a “buy” rating and set a $13.00 price target on shares of Zuora in a research note on Thursday, August 22nd. Robert W. Baird increased their price target on shares of Zuora from $8.00 to $10.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 28th. Finally, Craig Hallum cut shares of Zuora from a “buy” rating to a “hold” rating and decreased their price target for the stock from $12.00 to $10.00 in a research note on Monday, July 8th.
Check Out Our Latest Analysis on Zuora
Insiders Place Their Bets
Institutional Investors Weigh In On Zuora
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new position in Zuora in the 2nd quarter valued at approximately $44,000. CWM LLC increased its position in shares of Zuora by 25.0% in the second quarter. CWM LLC now owns 7,945 shares of the company’s stock valued at $79,000 after buying an additional 1,590 shares in the last quarter. Quent Capital LLC acquired a new position in shares of Zuora during the 1st quarter worth $83,000. Canada Pension Plan Investment Board purchased a new stake in shares of Zuora in the 2nd quarter worth about $85,000. Finally, Williams Financial LLC acquired a new stake in Zuora in the 2nd quarter valued at about $119,000. 83.02% of the stock is currently owned by institutional investors and hedge funds.
Zuora Trading Up 0.1 %
Shares of Zuora stock opened at $8.65 on Wednesday. The company has a fifty day simple moving average of $8.81 and a 200-day simple moving average of $9.24. Zuora has a 12-month low of $7.05 and a 12-month high of $10.85. The company has a current ratio of 2.77, a quick ratio of 2.77 and a debt-to-equity ratio of 1.90. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -20.12 and a beta of 1.72.
Zuora (NYSE:ZUO – Get Free Report) last issued its earnings results on Wednesday, August 21st. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.09. Zuora had a negative net margin of 10.60% and a negative return on equity of 12.54%. The business had revenue of $115.40 million during the quarter, compared to analysts’ expectations of $112.63 million. During the same quarter in the prior year, the business posted ($0.12) EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, equities analysts forecast that Zuora will post -0.06 EPS for the current fiscal year.
Zuora Company Profile
Zuora, Inc provides a monetization suite for modern businesses to help companies launch and scale new services and operate dynamic customer-centric business models. The company offers Zuora Billing that allows customers to deploy various pricing and packaging strategies to monetize their recurring revenue streams, bill customers, calculate prorations when subscriptions change, and automate billing and payment operations; Zuora Revenue, a revenue recognition and automation solution that accounting teams use to manage their complex revenue streams; Zuora Payments to provide payment orchestration services for companies looking to operate globally; and Zephr, a digital subscriber experience platform that helps companies orchestrate dynamic experiences that increase conversion, reduce churn, and nurture ongoing subscriber relationships.
Further Reading
- Five stocks we like better than Zuora
- Differences Between Momentum Investing and Long Term Investing
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Insider Trading – What You Need to Know
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 5 Top Rated Dividend Stocks to Consider
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Zuora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zuora and related companies with MarketBeat.com's FREE daily email newsletter.